Clinical samples from patients with acute or chronic non-A, B, C, D, E hepatitis in the United States are being studied for biological, serological or molecular evidence of transmissible agents. Patients with fulminant non-A, non-B hepatitis remain a diagnostic enigma and may be infected with one or more previously unrecognized viruses. We are attempting to discover the etiology of this disease. Evidence for the existence of an additional water-borne hepatitis virus has come from sero-epidemiologic studies in India and Saudi Arabia. We are attempting to transmit an agent from clinical specimens of such patients. Some years ago, a hepatitis virus was reported to be transmissible from a non-A, non-B hepatitis patient to marmoset (tamarin) monkeys. The agent, called the GB agent, could be serially transmitted in marmosets and was partially characterized. Recently the GB agent was cloned and sequenced and shown to be two separate viruses, each distantly related to hepatitis C virus as well as a previously unrecognized human virus. The GB agents and the newly discovered human virus are being studied in primates and in vitro. To date, the newly recognized human virus (HGV/GBV-C) has been transmitted to chimpanzees and the resulting infection characterized. In addition, several new viruses have been discovered in New World monkeys. These are being further characterized. Modern techniques of molecular biology have been used to discover new viruses in recent years. These are now being applied to prospectively collected sera from patients with transfusion-associated hepatitis in a search for new hepatitis viruses that may cause up to 15% of such hepatitis in the US.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000311-17
Application #
6098908
Study Section
Special Emphasis Panel (LID)
Project Start
Project End
Budget Start
Budget End
Support Year
17
Fiscal Year
1998
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Christensen, Peer B; Engle, Ronald E; Hjort, Charlotte et al. (2008) Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 47:1026-31
Purcell, R H; Emerson, S U (2008) Hepatitis E: an emerging awareness of an old disease. J Hepatol 48:494-503
Easterbrook, J D; Kaplan, J B; Vanasco, N B et al. (2007) A survey of zoonotic pathogens carried by Norway rats in Baltimore, Maryland, USA. Epidemiol Infect 135:1192-9
Yu, Claro; Zimmerman, Carl; Stone, Roger et al. (2007) Using improved technology for filter paper-based blood collection to survey wild Sika deer for antibodies to hepatitis E virus. J Virol Methods 142:143-50
Meky, Fatma A; Stoszek, Sonia K; Abdel-Hamid, Mohamed et al. (2006) Active surveillance for acute viral hepatitis in rural villages in the Nile Delta. Clin Infect Dis 42:628-33
Stoszek, Sonia K; Abdel-Hamid, Mohamed; Saleh, Doa'a A et al. (2006) High prevalence of hepatitis E antibodies in pregnant Egyptian women. Trans R Soc Trop Med Hyg 100:95-101
Stoszek, Sonia K; Engle, Ronald E; Abdel-Hamid, Mohamed et al. (2006) Hepatitis E antibody seroconversion without disease in highly endemic rural Egyptian communities. Trans R Soc Trop Med Hyg 100:89-94
Graff, Judith; Nguyen, Hanh; Yu, Claro et al. (2005) The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaques. J Virol 79:6680-9
Graff, Judith; Nguyen, Hanh; Kasorndorkbua, Chaiyan et al. (2005) In vitro and in vivo mutational analysis of the 3'-terminal regions of hepatitis e virus genomes and replicons. J Virol 79:1017-26
Emerson, Suzanne U; Arankalle, Vidya A; Purcell, Robert H (2005) Thermal stability of hepatitis E virus. J Infect Dis 192:930-3

Showing the most recent 10 out of 23 publications